Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $1.62 -0.18 (-10.00%) As of 01:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Stock Price Performance The Telomir Pharmaceuticals (TELO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.85%, with a year-to-date return of -59.34%. In the past month, the stock has increased 36.18%, reflecting recent market activity. As of the latest close, Telomir Pharmaceuticals traded at $1.80 with a market cap of $58.11 million and volume of 18.34 million shares. Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+19.64%1 Month Performance+36.18%3 Month Performance+43.16%Year-To-Date Performance-59.34%1 Year Performance-67.85% TELO Stock Chart for Wednesday, October, 8, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/07/2025$1.42$1.80+26.76%$1.86$1.6218.34 million shs$58.11 million10/06/2025$1.40$1.42+1.43%$1.42$1.379.69 million shs$45.84 million10/03/2025$1.39$1.40+0.72%$1.44$1.37188,499 shs$45.19 million10/02/2025$1.39$1.39$1.40$1.36185,292 shs$44.87 million10/01/2025$1.39$1.39$1.41$1.36230,747 shs$44.87 million09/30/2025$1.34$1.39+3.73%$1.40$1.34192,561 shs$44.87 million09/29/2025$1.39$1.34-3.60%$1.41$1.34263,590 shs$43.26 million09/26/2025$1.40$1.39-0.71%$1.46$1.34605,954 shs$44.87 million09/25/2025$1.52$1.40-7.89%$1.52$1.40463,059 shs$45.19 million09/24/2025$1.52$1.52$1.56$1.50321,405 shs$49.07 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/23/2025$1.56$1.52-2.56%$1.60$1.51528,075 shs$49.07 million09/22/2025$1.53$1.56+1.96%$1.58$1.46870,397 shs$50.36 million09/19/2025$1.40$1.53+9.29%$1.55$1.391.55 million shs$49.39 million09/18/2025$1.33$1.40+5.26%$1.43$1.321.08 million shs$45.19 million09/17/2025$1.30$1.33+2.31%$1.38$1.32254,477 shs$42.93 million09/16/2025$1.33$1.30-2.26%$1.34$1.30287,577 shs$41.97 million09/15/2025$1.36$1.33-2.21%$1.36$1.30422,015 shs$42.93 million09/12/2025$1.37$1.36-0.73%$1.41$1.36401,802 shs$43.90 million09/11/2025$1.26$1.37+8.73%$1.38$1.27718,043 shs$44.22 million09/10/2025$1.36$1.26-7.35%$1.35$1.221.12 million shs$40.67 million09/09/2025$1.23$1.36+10.57%$1.45$1.266.10 million shs$43.90 million09/08/2025$1.24$1.23-0.81%$1.25$1.20419,505 shs$39.70 million Related Companies Milestone Pharmaceuticals Stock Price Chart Avalo Therapeutics Stock Price Chart Protara Therapeutics Stock Price Chart Citius Oncology Stock Price Chart Innate Pharma Stock Price Chart Neoleukin Therapeutics Stock Price Chart SELLAS Life Sciences Group Stock Price Chart Seres Therapeutics Stock Price Chart BioHarvest Sciences Stock Price Chart Genelux Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
